X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Lupin Ltd with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs MYLAN (US) - Comparison Results

LUPIN    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN   MYLAN
EQUITY SHARE DATA
    LUPIN
Mar-18
MYLAN
Dec-18
LUPIN/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,4653,319-   
Low Rs7271,827-   
Sales per share (Unadj.) Rs349.61,527.3-  
Earnings per share (Unadj.) Rs5.641.5-  
Cash flow per share (Unadj.) Rs29.6327.4-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs300.31,652.2-  
Shares outstanding (eoy) m452.08514.50-   
Bonus/Rights/Conversions ESOPS--  
Price / Sales ratio x3.11.7 186.1%   
Avg P/E ratio x197.262.0 317.9%  
P/CF ratio (eoy) x37.17.9 471.6%  
Price / Book Value ratio x3.61.6 234.4%  
Dividend payout %90.00-   
Avg Mkt Cap Rs m495,5021,323,828 37.4%   
No. of employees `00017.035.0 48.7%   
Total wages/salary Rs m28,6470-   
Avg. sales/employee Rs Th9,273.622,451.1 41.3%   
Avg. wages/employee Rs Th1,681.00-   
Avg. net profit/employee Rs Th147.4609.6 24.2%   
INCOME DATA
Net Sales Rs m158,042785,787 20.1%  
Other income Rs m1,5040-   
Total revenues Rs m159,545785,787 20.3%   
Gross profit Rs m31,475203,333 15.5%  
Depreciation Rs m10,859147,130 7.4%   
Interest Rs m2,04437,794 5.4%   
Profit before tax Rs m20,07618,409 109.1%   
Minority Interest Rs m-710-   
Prior Period Items Rs m350-   
Extraordinary Inc (Exp) Rs m-14,6440-   
Tax Rs m2,885-2,929 -98.5%   
Profit after tax Rs m2,51321,337 11.8%  
Gross profit margin %19.925.9 77.0%  
Effective tax rate %14.4-15.9 -90.3%   
Net profit margin %1.62.7 58.5%  
BALANCE SHEET DATA
Current assets Rs m122,095438,783 27.8%   
Current liabilities Rs m50,956319,921 15.9%   
Net working cap to sales %45.015.1 297.6%  
Current ratio x2.41.4 174.7%  
Inventory Days Days8584 101.2%  
Debtors Days Days12093 128.5%  
Net fixed assets Rs m129,876152,430 85.2%   
Share capital Rs m904418 216.1%   
"Free" reserves Rs m134,8660-   
Net worth Rs m135,771850,078 16.0%   
Long term debt Rs m64,245917,507 7.0%   
Total assets Rs m263,0542,280,241 11.5%  
Interest coverage x10.81.5 727.9%   
Debt to equity ratio x0.51.1 43.8%  
Sales to assets ratio x0.60.3 174.3%   
Return on assets %1.72.6 66.8%  
Return on equity %1.92.5 73.7%  
Return on capital %3.73.2 117.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m33,8070-   
CASH FLOW
From Operations Rs m17,512163,287 10.7%  
From Investments Rs m-14,073-84,401 16.7%  
From Financial Activity Rs m-14,921-76,068 19.6%  
Net Cashflow Rs m-11,4821,353 -848.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 69.73 Rs / USD

Compare LUPIN With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare LUPIN With: PFIZER  J.B.CHEMICALS  ELDER PHARMA  NATCO PHARMA  STERLING BIOTECH  



Today's Market

Jet Airways and Yes Bank - What's Next for these Beaten Down Stocks?(Podcast)

Jet Airways and Yes Bank, both once market darlings are now being shunned by market participants. The National Stock Exchange (NSE) exchange notified that the shares of the airline.

Related Views On News

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

The Best 4 Small-cap Stocks to Buy(The 5 Minute Wrapup)

Jun 3, 2019

In the sometimes good sometimes bad market of small caps, there are strong buying opportunities available today. But this great opportunity won't last forever.

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Top 7 Stocks to Profit from Modi's Repeat Performance(Profit Hunter)

Jun 3, 2019

The long-term India story looks promising with the Modi government back in power. Which stocks are likely to go up the most?

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Jun 14, 2019 (Close)

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS